Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Eve vs Gala Health

By GLP-1 ScorecardUpdated

EveFactor scores not reassessed.
Site position #206

Lower score

Gala HealthFactor scores not reassessed.
Site position #11

Higher score

Score comparison

Gala Health has the higher recorded score — 82.9/100 to 66.3/100.

Gala Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Gala offers low advertised injection prices and a branded Ozempic path, but its campaign and longer-term plan pages need to be reconciled before paying.

Before you choose

Eve does not publish a semaglutide price, so its Eve review sets out what it does disclose, while the Gala Health review explains the conditions attached to Gala Health's figure. The semaglutide cost page compares published rates across the field. Ask Eve for a written total before treating either one as the cheaper choice.

If neither one fits, Eve vs You + Me (He & She MD) and Evernow vs Gala Health compare each of them with another graded program, and the list of alternatives to Eve ranks the programs closest to Eve on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueGala Health +29
55
84
Dose & formulationEve +5
88
83
Clinical oversightGala Health +6
79
85
Labs & monitoringGala Health +31
52
83
FulfillmentGala Health +21
67
88
Contract termsGala Health +25
41
66
Eve · top barGala Health · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricEveGala Health
WeighScore66.3/10082.9/100
GradeCB−
Site position#206#11
SemaglutideCurrent price not verifiedFrom $69/mo on the annual plan, billed once a year (campaign shows $129/mo; offers conflict—confirm billing term)
TirzepatideCurrent price not verifiedFrom $99/mo on the annual plan, billed once a year (campaign shows $179/mo; offers conflict—confirm term)
CoverageConfirm coverage for your stateCoverage wording differs: all 50 on homepage, most U.S. states in campaign
Brand-name accessYesYes
Oral / sublingualNot confirmedNot confirmed
Eve

Site position #206 · C

Factor scores not reassessed.

Strengths

  • Homepage lists Wegovy, Ozempic and Mounjaro
  • Terms identify Eve Health, Inc. and describe third-party care

What to consider

  • Current compounded prices and plan-specific cancellation terms remain unverified
Gala Health

Site position #11 · B−

Factor scores not reassessed.

Strengths

  • Campaign advertises $129 semaglutide and $179 tirzepatide with medication and telehealth visits included if prescribed
  • Brand-name Ozempic path and broader menopause/HRT services listed
  • Terms identify clinical practice networks; actual clinician and pharmacy assignment still need checking

What to consider

  • Annual-plan and no-contract campaign presentations differ; the lowest prices are advertised as billed once a year
  • Cancel at least 72 hours before renewal; ordinary cancellation does not produce a refund
  • Medical-disqualification refund wording differs between full-refund and remaining/current-cycle provisions
  • Dispensing pharmacy not identified for an individual order; oral option is a waitlist, not a current offer

Featured provider

Gala Health

Factor scores not reassessed.

Gala Health scores 82.9/100 (B−). Gala offers low advertised injection prices and a branded Ozempic path, but its campaign and longer-term plan pages need to be reconciled before paying.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard